Drug/Small Molecule:
chloramphenicol

2D structure

Overview

Generic Names: CAF; CAM; CAP; CPh; Chloramfenikol; Chloramphenicole; Chloroamphenicol; Cloroamfenicolo; D-Chloramphenicol
Trade Names: Ak-Chlor Ophthalmic Ointment; Ak-Chlor Ophthalmic Solution; Ak-chlor; Alficetyn; Ambofen; Amphenicol; Amphicol; Amseclor; Anacetin; Aquamycetin; Austracil; Austracol; Biocetin; Biophenicol; Catilan; Chemicetin; Chemicetina; Chlomin; Chlomycol; Chlora-Tabs; Chloracol Ophthalmic Solution; Chloramex; Chloramficin; Chloramfilin; Chloramsaar; Chlorasol; Chloricol; Chlornitromycin; Chloro-25 vetag; Chlorocaps; Chlorocid; Chlorocid S; Chlorocide; Chlorocidin C; Chlorocidin C tetran; Chlorocol; Chlorofair; Chlorofair Ophthalmic Ointment; Chlorofair Ophthalmic Solution; Chloroject L; Chloromax; Chloromycetin Hydrocortisone; Chloromycetin Ophthalmic Ointment; Chloromycetin Palmitate; Chloromycetin for Ophthalmic Solution; Chloromycetny; Chloromyxin; Chloronitrin; Chloroptic; Chloroptic Ophthalmic Solution; Chloroptic S.O.P.; Chloroptic-P S.O.P.; Chlorovules; Cidocetine; Ciplamycetin; Cloramfen; Cloramficin; Cloramicol; Cloramidina; Clorocyn; Cloromisan; Clorosintex; Comycetin; Cylphenicol; Desphen; Detreomycin; Detreomycine; Dextromycetin; Doctamicina; Econochlor; Econochlor Ophthalmic Ointment; Econochlor Ophthalmic Solution; Elase-Chloromycetin; Embacetin; Emetren; Enicol; Enteromycetin; Erbaplast; Ertilen; Farmicetina; Farmitcetina; Fenicol; Fenicol Ophthalmic Ointment; Globenicol; Glorous; Halomycetin; Hortfenicol; I-Chlor Ophthalmic Solution; Intramycetin; Isicetin; Ismicetina; Isophenicol; Isopto fenicol; Juvamycetin; Kamaver; Kemicetina; Kemicetine; Klorita; Klorocid S; Leukamycin; Leukomyan; Leukomycin; Levomicetina; Levomitsetin; Levomycetin; Loromisan; Loromisin; Mastiphen; Mediamycetine; Medichol; Micloretin; Micochlorine; Micoclorina; Microcetina; Mychel; Mychel-Vet; Mycinol; Normimycin V; Novochlorocap; Novomycetin; Novophenicol; Ocu-Chlor Ophthalmic Ointment; Ocu-Chlor Ophthalmic Solution; Oftalent; Oleomycetin; Opclor; Opelor; Ophtho-Chloram Ophthalmic Solution; Ophthochlor; Ophthochlor Ophthalmic Solution; Ophthoclor; Ophthocort; Ophtochlor; Optomycin; Otachron; Otophen; Pantovernil; Paraxin; Pentamycetin; Pentamycetin Ophthalmic Ointment; Pentamycetin Ophthalmic Solution; Quemicetina; Rivomycin; Romphenil; Ronphenil; Septicol; Sificetina; Sintomicetina; Sintomicetine R; Sno-Phenicol; Sopamycetin Ophthalmic Ointment; Sopamycetin Ophthalmic Solution; Spectro-Chlor Ophthalmic Ointment; Spectro-Chlor Ophthalmic Solution; Stanomycetin; Synthomycetin; Synthomycetine; Synthomycine; Tega-Cetin; Tevcocin; Tevcosin; Tifomycin; Tifomycine; Tiromycetin; Treomicetina; Tyfomycine; Unimycetin; Veticol; Viceton
Brand Mixtures: Actinac Pwr (Allantoin + Butoxyethyl Nicotinate + Chloramphenicol + Hydrocortisone Acetate + Sulfur); Actinac Pws (Allantoin + Butoxyethyl Nicotinate + Chloramphenicol + Hydrocortisone Acetate + Sulfur); Chlorasone (Chloramphenicol + Prednisolone Acetate); Elase Chloromycetin Ont (Chloramphenicol + Deoxyribonuclease Pancreatic + Fibrinolysin); Liquichlor (Chloramphenicol + Prednisolone + Squalane + Tetracaine); Ophthocort Ont (Chloramphenicol + Hydrocortisone Acetate + Polymyxin B); Sopamycetin/Hc Ointment (Chloramphenicol + Hydrocortisone Acetate); Sopamycetin/Hc Ont (Chloramphenicol + Hydrocortisone Acetate); Sopamycetin/Hc Susp (Chloramphenicol + Hydrocortisone Acetate); Zoomycetine Spray (Chloramphenicol + Isopropyl Alcohol + Methyl Violet)
PharmGKB Accession Id: PA448927

Description

An antibiotic first isolated from cultures of <i>Streptomyces venequelae</i> in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) (source: Drug Bank)

Indication

Used in treatment of cholera, as it destroys the vibrios and decreases the diarrhea. It is effective against tetracycline-resistant vibrios. It is also used in eye drops or ointment to treat bacterial conjunctivitis. (source: Drug Bank)

ATC Therapeutic Categories

  • D06AX:Other antibiotics for topical use
  • D10AF:Antiinfectives for treatment of acne
  • G01AA:Antibiotics
  • J01BA:Amphenicols
  • S01AA:Antibiotics
  • S02AA:Antiinfectives
  • S03AA:Antiinfectives

Pharmacology, Interactions, and Contraindications

Mechanism Of Action

Chloramphenicol is lipid-soluble, allowing it to diffuse through the bacterial cell membrane. It then reversibly binds to the 50S subunit of bacterial ribosomes where transfer of amino acids to growing peptide chains is prevented (perhaps by suppression of peptidyl transferase activity), thus inhibiting peptide bond formation and subsequent protein synthesis. (source: Drug Bank)

Pharmacology

Chloramphenicol is a broad-spectrum antibiotic that was derived from the bacterium Streptomyces venezuelae and is now produced synthetically. Chloramphenicol is effective against a wide variety of microorganisms, but due to serious side-effects (e.g., damage to the bone marrow, including aplastic anemia) in humans, it is usually reserved for the treatment of serious and life-threatening infections (e.g., typhoid fever). Chloramphenicol is bacteriostatic but may be bactericidal in high concentrations or when used against highly susceptible organisms. Chloramphenicol stops bacterial growth by binding to the bacterial ribosome (blocking peptidyl transferase) and inhibiting protein synthesis. (source: Drug Bank)

Food Interactions

Take on an empty stomach. (source: Drug Bank)

Absorption, Distribution, Metabolism, Elimination & Toxicity

Biotransformation

Hepatic, with 90% conjugated to inactive glucuronide. (source: Drug Bank)

Protein Binding

Plasma protein binding is 50-60% in adults and 32% is premature neonates. (source: Drug Bank)

Absorption

Rapidly and completely absorbed from gastrointestinal tract following oral administration (bioavailability 80%). Well absorbed following intramuscular administration (bioavailability 70%). Intraocular and some systemic absorption also occurs after topical application to the eye. (source: Drug Bank)

Toxicity

Oral, mouse: LD<sub>50</sub> = 1500 mg/kg; Oral, rat: LD<sub>50</sub> = 2500 mg/kg. Toxic reactions including fatalities have occurred in the premature and newborn; the signs and symptoms associated with these reactions have been referred to as the gray syndrome. Symptoms include (in order of appearance) abdominal distension with or without emesis, progressive pallid cyanosis, vasomotor collapse frequently accompanied by irregular respiration, and death within a few hours of onset of these symptoms. (source: Drug Bank)

Isomeric SMILES Code:

c1cc(ccc1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)N(=O)=O (source: Drug Bank)

The following genes are in curated knowledge about this drug.

  Gene Relationship Evidence
Phenotype data available Genotype Data Available Literature annotations available Not annotated
UGT2B7
  •   
  •   
  • PK
  •   
  •   
Publications

A list of non-curated publications that mention this drug along with other genes is available.

Drug Targets

Gene Description
CD55 Uncurated Annotation (source: Drug Bank)

The following drugs are in curated knowledge about this drug.

  Drug Relationship Evidence
Phenotype data available Genotype Data Available Literature annotations available Not annotated
warfarin
  •   
  •   
  •   
  •   
  •   
Publications

A list of non-curated publications that mention this drug along with other drugs is available.

Drug Interactions

Drug Description
acenocoumarol Uncurated Annotation Increases the anticoagulant effect (source: Drug Bank)
chlorpropamide Uncurated Annotation The agent increases the effect of sulfonylurea (source: Drug Bank)
cyclosporine Uncurated Annotation Increases the effect of cyclosporine (source: Drug Bank)
dicumarol Uncurated Annotation Increases the anticoagulant effect (source: Drug Bank)
glibenclamide Uncurated Annotation The agent increases the effect of sulfonylurea (source: Drug Bank)
gliclazide Uncurated Annotation The agent increases the effect of sulfonylurea (source: Drug Bank)
glipizide Uncurated Annotation The agent increases the effect of sulfonylurea (source: Drug Bank)
mephenytoin Uncurated Annotation Increases phenytoin, modifies chloramphenicol (source: Drug Bank)
phenytoin Uncurated Annotation Increases phenytoin, modifies chloramphenicol (source: Drug Bank)
rifampin Uncurated Annotation Rifampin decreases the effect of chloramphenicol (source: Drug Bank)
tacrolimus Uncurated Annotation Increases tacrolimus levels (source: Drug Bank)
tolbutamide Uncurated Annotation The agent increases the effect of sulfonylurea (source: Drug Bank)
warfarin Uncurated Annotation Increases the anticoagulant effect (source: Drug Bank)

Non-Curated Information

A list of non-curated publications that mention this drug along with other diseases is available.

LinkOuts

Web Resource:
Wikipedia
DrugBank:
DB00446
ChEBI ID:
17698
KEGG Compound ID:
C00918
KEGG Drug ID:
D00104
PubChem Compound ID:
298
PubChem Substance ID:
4172

Common Searches

Search PubMed
Search Medline Plus
Search PubChem
Search CTD

Non-Curated Publications

A list of non-curated publications that mention this drug is available.

PharmGKB integrates drug information from different sources: DrugBank, Open Eye Scientific Software.
Add New Alternate Name
Add New ATC Term
Add Cross Reference
Add a metabolite
Add a text annotation
Add a drug target
hint: enter a gene
    Add a drug interaction
    hint: enter a drug
    PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (GM61374).
    ©2001-2010 PharmGKB.